![](/img/cover-not-exists.png)
Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease
Huttenlocher, Johanna, Stefansson, Hreinn, Steinberg, Stacy, Helgadottir, Hafdis T., Sveinbjörnsdóttir, Sigurlaug, Riess, Olaf, Bauer, Peter, Stefansson, KariLanguage:
english
Journal:
Human Molecular Genetics
DOI:
10.1093/hmg/ddv277
Date:
July, 2015
File:
PDF, 613 KB
english, 2015